Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
insitro
3161
insitro
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Life Sciences
We're using #machinelearning and highthroughput biology to transform the way that drugs are discovered and delivered to patients.
Suggest edits
Type
B2b
Founded
2018
Raised
$543M
Follow us
Also headquartered in South San Francisco
Genentech
MyoKardia
Freenome
SuccessFactors
Plenty
Sutro Biopharma
Theravance
Dispatch
Counsyl
Kinestral Technologies, Inc.
Companies in the same industry
C4X Discovery Ltd
Ark Biosciences
BioDelivery Sciences International
Castle Creek Biosciences
Cellectis
SkyQuest Technology Consulting Private Limited
Suzhou Kintor Pharmaceuticals
CANbridge Life Sciences Ltd.
Antengene Corporation
Vaxess Technologies
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$400,000,000
Venture capital (Series C) - 2021
Foresite Capital
Two Sigma Ventures
T. Rowe Price
+7
$143,000,000
Venture capital (Series B) - 2020
Andreessen Horowitz
Foresite Capital
Two Sigma Ventures
+5
Team Size
1–10
Employees
I work here
Location
South San Francisco
,
United States
Headquarters
Explore South San Francisco
$400,000,000
Venture capital (Series C)
neurons.AI
insitro raises $400M for machine learning-powered drug discovery efforts
neurons.AI
insitro raises $400M for machine learning-powered drug discovery efforts
neurons.AI
insitro Raises $400 Million in Series C Financing
neurons.AI
insitro Raises $400 Million in Series C Financing
neurons.AI
BMS joins forces with insitro to develop neurodegenerative treatments
$143,000,000
Venture capital (Series B)
FinSMEs
,
neurons.AI
,
PrivateEquityWire
, +1
insitro Raises $143M in Series B Financing
PE HUB
VC-backed Insitro beefs up team with two new appointments
Medium
insitro: Rethinking drug discovery using machine learning
Technology
People
Health
